Preliminary Results From The Flu/Cy/Alemtuzumab Arm Of The Phase I Balli-01 Trial Of Ucart22, An Anti-Cd22 Allogeneic Car-T Cell Product, In Patients With Relapsed/Refractory (R/R) Cd22+ B-Cell All
UCART22
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preliminary Results From The Flu/Cy/Alemtuzumab Arm Of The Phase I Balli-01 Trial Of Ucart22, An Anti-Cd22 Allogeneic Car-T Cell Product, In Patients With Relapsed/Refractory (R/R) Cd22+ B-Cell All ### Output: UCART22